Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities
Net income (loss)	$ (4,591,284)	$ 116,756
Adjustments to reconcile net income (loss) to cash used in operating activities:
Depreciation	122,736	513,029
Amortization of intangibles		65,988
Amortization of deferred finance costs		24,657
Non-cash lease expense	2,342,344
Share-based compensation	1,330,195	560,973
Net impairment and loss on asset disposal		94,931
Adjustment of warrants		(2,590,361)
Provision for obsolete inventory		320,447
Changes in operating assets and liabilities:
Accounts receivable	(308,466)	(733,856)
Inventories	(655,864)	(365,142)
Prepaid expenses and other current assets	(507,222)	(124,419)
Other assets	(19,738)	26,775
Accounts payable	372,737	72,259
Accrued liabilities	560,482	(552,766)
Deferred revenue	(585,974)	(81,945)
Operating lease liability	(2,290,682)
Other liabilities	(385,944)	106,092
Net cash used in operating activities	(4,616,680)	(2,546,582)
Cash flows from investing activities
Purchase of fixed assets	(29,486)	(265,482)
Net cash used in investing activities	(29,486)	(265,482)
Cash flows from financing activities
Proceeds from issuance of stock, net of issuance costs	24,032,209	57,137
Proceeds from warrant exercise		9,864,697
Net cash provided by financing activities	24,032,209	9,921,834
Net increase in cash and cash equivalents	19,386,043	7,109,770
Cash and cash equivalents at beginning of period	10,796,072	3,686,302
Cash and cash equivalents at end of period	30,182,115	10,796,072
Supplemental disclosures of cash flow information:
Interest Paid